Athenex Appoints Darrel P. Coh - GuruFocus.com
GuruFocus Article or News written by GuruFocusNews and the topic is about:
Stay updated with breaking news from Src Kinase. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
GuruFocus Article or News written by GuruFocusNews and the topic is about:
Over the past ten years, Athenex has established a productive relationship with GenScript and GenScript ProBio as a provider of high-quality reagents and materials to support multiple Research and Development initiatives
BUFFALO, N.Y., June 08, 2022 (GLOBE NEWSWIRE) -- Athenex, Inc., (NASDAQ: ATNX), a global biopharmaceutical company dedicated to the discovery,...
52-week low: $3.66 Company Profile Athenex Inc is a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the treatment of cancer. Its current clinical pipeline is derived from Orascovery, based on a P-glycoprotein (P-gp) pump inhibitor, Src Kinase inhibition, T-cell receptor-engineered T-cells, and arginine deprivation therapy technology platforms. It is primarily engaged in conducting research and development activities through corporate collaborators, in-licensing and out-licensing pharmaceutical compounds and technology, cond...